Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Panbela Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 9 | 7 | −2 |
| Shares | 410.9K | 57.2K | −353.7K (−86.1%) |
| Value | $945.1K | $71.8K | −$873.3K (−92.4%) |
New holders (2)
Institutions that held Panbela Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 35,856 | $44.8K | 0.00% |
| Geode Capital Management, LLC | 15,886 | $19.9K | 0.00% |
Sold out (4)
Institutions that held Panbela Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sabby Management, LLC | 235,819 | $542.4K |
| Walleye Capital LLC | 94,536 | $217.4K |
| Hudson Bay Capital Management LP | 76,000 | $174.8K |
| UBS Group AG | 823 | $1.89K |